{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:23Z","timestamp":1788498983200,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Recombinant humanized type III collagen is widely used in facial rejuvenation due to its excellent biocompatibility and overall favorable safety profile; however, severe systemic hypersensitivity reactions are exceedingly rare. We report a case of a 47-year-old woman with no prior history of allergy who received topical lidocaine to the face, followed by injection of recombinant humanized type III collagen lyophilized fibers for skin texture improvement. Immediately after the injection, she developed suspectedly severe anaphylactic shock temporally associated with the recombinant collagen injectionpresenting with confusion, respiratory distress, followed by marked bradycardia (33 beats\/min), and loss of palpable arterial pulse. Emergency protocols were activated immediately, including cardiopulmonary resuscitation, intravenous adrenaline, corticosteroids, and fluid resuscitation. The patient\u2019s vital signs gradually recovered, and she was discharged after complete recovery two days later after complete recovery. This case suggests that recombinant humanized collagen, as a macromolecular protein, inherently carries\u00a0the risk of triggering immediate-type anaphylactic shock\u00a0despite its favorable safety profile. Clinicians should perform rigorous preoperative assessment, adhere to standardized procedures, and be proficient in the emergency management of anaphylactic shock to minimize the risk of severe adverse reactions and ensure medical safety.<\/jats:p>","DOI":"10.3389\/falgy.2026.1901705","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:00Z","timestamp":1788496020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe anaphylactic shock suspectedly induced by injection of recombinant humanized type III collagen lyophilized fiber for facial skin improvement: a case report"],"prefix":"10.3389","volume":"7","author":[{"given":"Junjie","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Yixing Traditional Chinese Medicine Hospital","place":["Yixing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yan","sequence":"additional","affiliation":[{"name":"Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Jiangnan University Medical Center","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Wuxi Xinwu District Hongshan Hospital","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, General Hospital of Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","first-page":"1","article-title":"Expert consensus on the operation specifications of collagen periorbital filling","volume":"12","author":"Chen","year":"2022","journal-title":"Chin Med Cosmetol"},{"key":"B2","first-page":"56","article-title":"Operation specification of recombinant type \u2162 humanized collagen injection technology","volume":"13","author":"Yan","year":"2023","journal-title":"Chin Med Cosmetol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.joms.2019.08.003","article-title":"Complications and litigation associated with injectable facial fillers: a cross-sectional study","volume":"78","author":"Beauvais","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1111\/jocd.15769","article-title":"An experimental study of the vascular embolism caused by recombinant type III collagen implants and hyaluronic acid","volume":"22","author":"Sun","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1039\/d3tb00438d","article-title":"Electrospun nanofibrous membranes of recombinant human collagen type III promote cutaneous wound healing","volume":"11","author":"Dong","year":"2023","journal-title":"J Mater Chem B"},{"key":"B6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.anai.2023.12.012","article-title":"Utility of food allergy thresholds","volume":"132","author":"Li","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B9","first-page":"160","article-title":"Anaphylactic reactions to local anesthetics: a review of the literature from 1950 to 2011 and presentation of 54 cases","volume":"22","author":"Trautmann","year":"2013","journal-title":"Allergo J Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1081-1206(10)61680-8","article-title":"Evaluation of adverse reactions to local anesthetics:experience with 236 patients","volume":"91","author":"Berkun","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1016\/j.jaip.2025.08.019","article-title":"Idiopathic anaphylaxis","volume":"13","author":"Ben-Shoshan","year":"2025","journal-title":"J All Clin Immunol Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12630-010-9275-7","article-title":"Local anesthetic systemic toxicity","volume":"57","author":"Dillane","year":"2010","journal-title":"Can J Anaesth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaci.2010.06.022","article-title":"The diagnosis and management of anaphylaxis practice parameter: 2010 update","volume":"126","author":"Lieberman","year":"2010","journal-title":"J All Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.bja.2019.01.031","article-title":"Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review","volume":"123","author":"Ebo","year":"2019","journal-title":"Br J Anaesth"},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 Update of the evidence base: world allergy organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J All Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.emc.2021.08.004","article-title":"Anaphylaxis: emergency department treatment","volume":"40","author":"McHugh","year":"2022","journal-title":"Emerg Med Clin North Am"},{"key":"B18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7861\/clinmed.2022-0073","article-title":"Emergency treatment of anaphylaxis: concise clinical guidance","volume":"22","author":"Whyte","year":"2022","journal-title":"Clin Med (Lond)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1016\/j.jaip.2025.04.018","article-title":"Benefits of epinephrine for anaphylaxis outweigh potential harm\u2014a safety review","volume":"13","author":"Bernstein","year":"2025","journal-title":"J All Clin Immunol Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/cea.14514","article-title":"Management of refractory anaphylaxis: an overview of current guidelines","volume":"54","author":"Pouessel","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/CCID.S315711","article-title":"The 10-point plan 2021: updated concepts for improved procedural safety during facial filler treatments","volume":"14","author":"Heydenrych","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1111\/j.1524-4725.2008.34253.x","article-title":"ASDS Guidelines of care: injectable fillers","volume":"34","author":"Alam","year":"2008","journal-title":"Dermatol Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/jocd.14074","article-title":"Hypersensitivity reaction to hyaluronic acid dermal filler following novel coronavirus infection - a case report","volume":"20","author":"Rowland-Warmann","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ajd.13273","article-title":"Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes","volume":"61","author":"Goodman","year":"2020","journal-title":"Australas J Dermatol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1901705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:02Z","timestamp":1788496022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1901705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":24,"alternative-id":["10.3389\/falgy.2026.1901705"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1901705","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1901705"}}